BIOTECHNOLOGY AND LIFE SCIENCES products beginning with : A
Anti-CD3E (Foralumab)-MC-MMAF ADC (1 supplier)
Anti-CD3E (Foralumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-CD3E (Foralumab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-CD3E (Foralumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-CD3E (Foralumab)-SMCC-DM1 ADC (1 supplier)
Anti-CD3E (Foralumab)-SPDB-DM4 ADC (1 supplier)
Anti-CD3E (Muromonab)-MC-MMAF ADC (1 supplier)
Anti-CD3E (Muromonab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-CD3E (Muromonab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-CD3E (Muromonab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-CD3E (Muromonab)-SMCC-DM1 ADC (1 supplier)
Anti-CD3E (Muromonab)-SPDB-DM4 ADC (1 supplier)
Anti-CD3E (Otelixizumab)-MC-MMAF ADC (1 supplier)
Anti-CD3E (Otelixizumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-CD3E (Otelixizumab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-CD3E (Otelixizumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-CD3E (Otelixizumab)-SMCC-DM1 ADC (1 supplier)
Anti-CD3E (Otelixizumab)-SPDB-DM4 ADC (1 supplier)
Anti-CD3E (Pasotuxizumab)-MC-MMAF ADC (1 supplier)
Anti-CD3E (Pasotuxizumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-CD3E (Pasotuxizumab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-CD3E (Pasotuxizumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-CD3E (Pasotuxizumab)-SMCC-DM1 ADC (1 supplier)
Anti-CD3E (Pasotuxizumab)-SPDB-DM4 ADC (1 supplier)
Anti-CD3E (Visilizumab)-MC-MMAF ADC (1 supplier)
Anti-CD3E (Visilizumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-CD3E (Visilizumab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-CD3E (Visilizumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-CD3E (Visilizumab)-SMCC-DM1 ADC (1 supplier)
Anti-CD3E (Visilizumab)-SPDB-DM4 ADC (1 supplier)
Anti-CD3E Neutralizing Antibody (V3S-0622-YC1300) (1 supplier)
Anti-CD4 (Cedelizumab)-MC-MMAF ADC (1 supplier)
Anti-CD4 (Cedelizumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-CD4 (Cedelizumab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-CD4 (Cedelizumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-CD4 (Cedelizumab)-SMCC-DM1 ADC (1 supplier)
Anti-CD4 (Cedelizumab)-SPDB-DM4 ADC (1 supplier)
Anti-CD4 (Clenoliximab)-MC-MMAF ADC (1 supplier)
Anti-CD4 (Clenoliximab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-CD4 (Clenoliximab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-CD4 (Clenoliximab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-CD4 (Clenoliximab)-SMCC-DM1 ADC (1 supplier)
Anti-CD4 (Clenoliximab)-SPDB-DM4 ADC (1 supplier)
Anti-CD4 (ECD domain) Neutralizing Antibody (V3S-0622-YC4331) (1 supplier)
Anti-CD4 (ECD domain) Neutralizing Antibody (V3S-0622-YC4333) (1 supplier)
Anti-CD4 (Ibalizumab)-MC-MMAF ADC (1 supplier)
Anti-CD4 (Ibalizumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-CD4 (Ibalizumab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-CD4 (Ibalizumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-CD4 (Ibalizumab)-SMCC-DM1 ADC (1 supplier)
Anti-CD3E (Foralumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-CD3E (Foralumab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-CD3E (Foralumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-CD3E (Foralumab)-SMCC-DM1 ADC (1 supplier)
Anti-CD3E (Foralumab)-SPDB-DM4 ADC (1 supplier)
Anti-CD3E (Muromonab)-MC-MMAF ADC (1 supplier)
Anti-CD3E (Muromonab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-CD3E (Muromonab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-CD3E (Muromonab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-CD3E (Muromonab)-SMCC-DM1 ADC (1 supplier)
Anti-CD3E (Muromonab)-SPDB-DM4 ADC (1 supplier)
Anti-CD3E (Otelixizumab)-MC-MMAF ADC (1 supplier)
Anti-CD3E (Otelixizumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-CD3E (Otelixizumab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-CD3E (Otelixizumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-CD3E (Otelixizumab)-SMCC-DM1 ADC (1 supplier)
Anti-CD3E (Otelixizumab)-SPDB-DM4 ADC (1 supplier)
Anti-CD3E (Pasotuxizumab)-MC-MMAF ADC (1 supplier)
Anti-CD3E (Pasotuxizumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-CD3E (Pasotuxizumab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-CD3E (Pasotuxizumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-CD3E (Pasotuxizumab)-SMCC-DM1 ADC (1 supplier)
Anti-CD3E (Pasotuxizumab)-SPDB-DM4 ADC (1 supplier)
Anti-CD3E (Visilizumab)-MC-MMAF ADC (1 supplier)
Anti-CD3E (Visilizumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-CD3E (Visilizumab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-CD3E (Visilizumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-CD3E (Visilizumab)-SMCC-DM1 ADC (1 supplier)
Anti-CD3E (Visilizumab)-SPDB-DM4 ADC (1 supplier)
Anti-CD3E Neutralizing Antibody (V3S-0622-YC1300) (1 supplier)
Anti-CD4 (Cedelizumab)-MC-MMAF ADC (1 supplier)
Anti-CD4 (Cedelizumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-CD4 (Cedelizumab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-CD4 (Cedelizumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-CD4 (Cedelizumab)-SMCC-DM1 ADC (1 supplier)
Anti-CD4 (Cedelizumab)-SPDB-DM4 ADC (1 supplier)
Anti-CD4 (Clenoliximab)-MC-MMAF ADC (1 supplier)
Anti-CD4 (Clenoliximab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-CD4 (Clenoliximab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-CD4 (Clenoliximab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-CD4 (Clenoliximab)-SMCC-DM1 ADC (1 supplier)
Anti-CD4 (Clenoliximab)-SPDB-DM4 ADC (1 supplier)
Anti-CD4 (ECD domain) Neutralizing Antibody (V3S-0622-YC4331) (1 supplier)
Anti-CD4 (ECD domain) Neutralizing Antibody (V3S-0622-YC4333) (1 supplier)
Anti-CD4 (Ibalizumab)-MC-MMAF ADC (1 supplier)
Anti-CD4 (Ibalizumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-CD4 (Ibalizumab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-CD4 (Ibalizumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-CD4 (Ibalizumab)-SMCC-DM1 ADC (1 supplier)
